Close
Back to ADVZ Stock Lookup

(ADVZ) – Press Releases

Nov 18, 2021 02:00 AM ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth
May 14, 2021 07:00 AM ADVANZ PHARMA Corp. Limited Announces First Quarter 2021 Results
Mar 17, 2021 07:00 AM ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results
Jan 27, 2021 03:25 AM ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital
Nov 6, 2020 07:00 AM ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results
Oct 23, 2020 07:00 AM ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results
Aug 12, 2020 07:00 AM ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results
Jul 29, 2020 05:00 PM ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results
Jun 17, 2020 04:00 PM ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders
May 27, 2020 11:42 AM ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.
May 13, 2020 07:00 AM ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results
Apr 1, 2020 05:40 PM ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
Mar 30, 2020 07:00 AM Correvio Reports Full Year 2019 Financial Results
Mar 27, 2020 05:00 PM ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange
Mar 25, 2020 07:00 AM ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results
Mar 16, 2020 07:00 AM ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
Mar 16, 2020 07:00 AM ADVANZ PHARMA to Acquire Correvio
Mar 11, 2020 05:00 PM ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results
Mar 10, 2020 07:00 AM ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange
Mar 6, 2020 07:00 AM ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
Feb 12, 2020 07:00 AM ADVANZ PHARMA Corp. Limited Comments on CMA Supplemental Statement of Objections Related to Hydrocortisone Tablets
Jan 8, 2020 05:00 PM ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe
Dec 17, 2019 05:00 PM ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders
Nov 27, 2019 07:00 AM ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe
Nov 7, 2019 07:00 AM ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results
Oct 24, 2019 07:00 AM ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results
Aug 7, 2019 07:00 AM ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results
Jul 25, 2019 07:00 AM ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin
Jul 24, 2019 07:00 AM ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results
Jun 17, 2019 06:20 PM ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders
Jun 11, 2019 08:49 AM ADVANZ PHARMA Corp. Announces Non-Deal Roadshow for European-based Debt Investors
May 23, 2019 07:00 AM ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine
May 10, 2019 07:00 AM ADVANZ PHARMA Corp. Announces First Quarter 2019 Results
Apr 26, 2019 07:00 AM ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results
Apr 1, 2019 07:00 AM ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines
Apr 1, 2019 07:00 AM ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines
Mar 14, 2019 07:00 AM ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results
Jan 30, 2019 07:30 AM ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections

Back to ADVZ Stock Lookup